Omnicell Inc (OMCL)
Omnicell, Inc. is a healthcare technology company listed on NASDAQ under the ticker OMCL. The company serves healthcare providers in the United States and international markets with solutions designed to support medication management, workflow automation, and pharmacy operations. Its offerings include point-of-care tools for clinician workflows, automated dispensing systems such as Titan XT, Central Pharmacy Dispensing Service, Central Med Automation Service, and IV Compounding Service. Omnicell also provides specialty pharmacy services, the EnlivenHealth platform for retail and community pharmacies, medication adherence products, and professional services covering implementation, training, and program management. Additional capabilities include post-installation support, maintenance, software upgrades, and traceability tools for medicines and medical supplies, along with the cloud-based OmniSphere platform. Founded in 1992 and headquartered in Fort Worth, Texas, the company was previously known as Omnicell Technologies, Inc. before adopting its current name in 2001.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-OMCL
|
$62.60
|
44.1% Upside
|
Undervalued
|
$61.29
|
41.1% Upside
|
Undervalued
|
Good
|
—
|
—
|
—
|
0.0%
|
July 30, 2026
|
98.3x
|
1.6x
|
1.6x
|
2.057 B
|
1.971 B
|
9.0%
|
92.2%
|
3.7
|
—
|
547.0%
|
